Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2003
10/22/2003EP1353917A2 Novel process for the synthesis of 5-(4-fluorophenyl)-1-(2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353915A2 Therapeutic chroman compounds
10/22/2003EP1353914A2 Therapeutic chromone compounds
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1159276B1 Benzofuran-2-ones as colorants for organic materials
10/22/2003EP1089993B1 5-ht1f agonists
10/22/2003EP1007523B1 Indole and 2,3-dihydroindole derivatives, their preparation and use
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003EP0699069B9 Endothelin receptor antagonists
10/22/2003CN1451002A Indole derivatives for treating central nervous system disease
10/22/2003CN1451001A Chromanone derivatives
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450993A Fungicidal heterocyclic aromatic amides and their compositions methods of use and preparation
10/22/2003CN1450992A Piperazine derivatives used as CCR5 antagonists
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1125067C Crystalline antifungal polymorph
10/22/2003CN1125066C Tetrahydrofuran phosphate-and hydroxy esters as prodrugs for corresponding antifungal agent
10/22/2003CN1125064C 3-pyridyl enantiomers and their use as analgesics
10/22/2003CN1125062C Dihydrobenzofuran and related compounds useful useful as anti-inflammatory agents
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1125052C Substituted isoquinoline derivatives and their use as anticonvulsants
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/22/2003CN1124841C Cosmetic skin lightening product for topical application
10/21/2003US6635771 N-benzhydryl indole compounds
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635668 Imidazoline receptor binding compounds
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists
10/21/2003US6635657 Pyridine derivatives; anticoagulants
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635649 Piperazinedione compounds
10/21/2003US6635647 Decahydro-isoquinolines
10/21/2003US6635643 For treating conditions which are related to impairment of gastric emptying
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635639 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084949A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084464A2 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
10/16/2003WO2003048152A3 Inflammation modulators
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002059084A3 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
10/16/2003US20030195353 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo- tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
10/16/2003US20030195352 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
10/16/2003US20030195340 Chromene compound
10/16/2003US20030195247 Antagonists of protein tryosin phosphatase 1B (PTP-1B) and T-cell protein tyrosine phosphatase (TC-PTP), used as antidiabetic agents and for prophylaxis of insulin resistance
10/16/2003US20030195244 Nitrogen compounds such as (6-Methoxy-1H-indol-3-yl)-(3,4,5-trimethoxy-phenyl)-methanone, administered for prophylaxis of cancer; angiogenesis inhibitors
10/16/2003US20030195239 Heterocyclic esters such as 6-cyclopentyl-6-(4-phenyl-but-3-ynyl)-dihydropyran-2,4-dione, used as enzyme inhibitors or for prophylaxis of virus infections
10/16/2003US20030195233 Carbocyclic secondary amides such as 2-(4-fluoro-phenoxy) -N-(4-((2-hydroxy-3-methyl-benzoyl amino)-methyl)-benzyl)-nicotinamide, administered for prophylaxis of respiratory system disorders
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195215 Compounds effective as beta-2 adrenoreceptor agonists as well pde4-inhibitors
10/16/2003US20030195213 A methylene-4-oxo-2-thionothiazolidin derivatives viricides for treating infections caused by Flavivirous
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195208 Phthalimido derivatives and a process for their preparation
10/16/2003US20030195204 Quinoline derivatives as NK3 antagonists
10/16/2003US20030195203 Heterocyclic derivatives
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195195 Substituted pyridines having antiangiogenic activity
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195193 Useful as activated blood coagulation factor X inhibitor; useful as an anticoagulant or an agent for prophylaxis and therapy of diseases caused by thrombus or embolus
10/16/2003US20030195192 Nicotinamides having antiangiogenic activity
10/16/2003US20030195190 For therapy of allergic rhinitis, ulcer or anorexia, diabetes, Alzheimer's disease, narcolepsy or attention deficit disorder
10/16/2003US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse
10/16/2003US20030194375 Anti-epileptogenic agents
10/16/2003CA2694410A1 Pyridinoylpiperidines as 5-ht1f agonists
10/15/2003EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
10/15/2003EP1351956A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351940A1 Substituted quinolines for the treatment of protozoan and retrovirus co-infections
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351930A2 Protease inhibitors
10/15/2003EP1351691A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/15/2003EP1351688A1 Urotensin-ii receptor antagonists
10/15/2003EP1268471B1 N-heterocyclic derivatives as nos inhibitors
10/15/2003EP1265873B1 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1228041B1 Indole derivatives and their use as 5ht2a ligands
10/15/2003EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
10/15/2003EP1098890B1 Dihydrotriazolone derivatives as pesticides
10/15/2003EP0973747B1 Pesticidal 1-arylpyrazoles
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1448142A Compositions comprising cytosine derivatives for the treatment of cancer
10/15/2003CN1124262C Indole derivatives useful as endothelin receptor antagonists
10/14/2003US6632833 2-(2-methylphenyl)-3,4-dihydro-2H-pyrrole derivatives
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists
1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 694